Medscape

FDA Panel Split on Safety of Long-Acting Testosterone

An advisory panel to the US Food and Drug Administration (FDA) was split today on the question of whether or not testosterone undecanoate intramuscular injection (Aveed, Endo Pharma Solutions) is a ...
FiercePharma

U.S. FDA Approves AVEED™ (Testosterone Undecanoate) Injectable Testosterone Replacement Therapy For Men Living With Hypogonadism, Or Low-T

AVEED offers distinct dosing schedule to increase testosterone levels in hypogonadal men, and underscores Endo's strategy and commitment to addressing health issues facing men DUBLIN, March 6, 2014 ...
Medscape

FDA Rejects Long-Acting Testosterone Injection for Third Time

The Food and Drug Administration (FDA) has, for the third time, declined approval of the long-acting testosterone undecanoate injection product (Aveed, Endo Pharma Solutions) for the treatment of men ...
Nature

Are long-acting intramuscular testosterone injections safe?

Testosterone substitution in male hypogonadism is a recognized tool to treat symptomatic patients. Various forms of this treatment exist including a long-acting intramuscular form using testosterone ...
The Holland Sentinel

Perrigo confirms patent for generic version of Aveed injection

Perrigo Company plc recently announced that it has filed an abbreviated new drug application for testosterone undecanoate injection with the U.S. Food and Drug Administration, and that it has notified ...
Healio

Testosterone therapy shows promise as potential weight-loss tool

NEW ORLEANS — Men with obesity and hypogonadism who underwent testosterone therapy achieved greater 10-year weight loss and experienced protective effects against cardiovascular and mortality risks ...
EurekAlert!

Study finds oral testosterone therapy undecanoate is effective, with no liver toxicity

WASHINGTON--An industry-supported study of an oral testosterone replacement therapy (TRT), testosterone undecanoate (TU, brand name Jatenzo) finds it is an effective, long-term treatment for men with ...